Purchase Order 36C25626P0103
- Not listed
- Abbott Laboratories, through its Abbott Vascular Inc. division, has been awarded a $56,292 delivery order against the Department of Veterans Affairs' VISN 20 indefinite-delivery/indefinite-quantity contract vehicle to provide surgical implants to the agency. As the prime contractor, Abbott Vascular will supply these products to various VA medical centers located in St. Paul, Minnesota through October 2023 on a firm fixed price basis. No subcontractors or set-aside designations were identified....
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $71,000 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The contract calls for an upgrade to the OPTIS System and COROFLOW System to support the agency's healthcare programs for veterans. Abbott Vascular will provide specialized medical device equipment and services. No set-aside designation was specified for this...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $42,671 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23. The award is to provide prosthetics in the form of an Eterna 16 Channel IPG, as described in the original solicitation. Abbott Vascular specializes in cardiovascular medical devices and has previously delivered a range of products to VA networks and facilities...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $49,824 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4. The contract calls for the delivery of implantable pulse generators to support healthcare services for veterans. Abbott Vascular specializes in cardiovascular medical devices and has previously provided a range of products to VA networks and facilities through...
- This $105,425.00 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 12 to Abbott Laboratories Inc.'s Abbott Vascular Inc. division. The contract, which does not have a set-aside designation, is for the delivery of various cardiovascular medical devices and services to support VA hospitals and clinics in meeting the healthcare needs of veterans. Abbott Vascular, a large medical device...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a firm fixed-price purchase order valued at $31,693.60 by the Department of Veterans Affairs' Veterans Integrated Service Network 12 for an LVAD (Left Ventricular Assist Device) system for veteran patient care. The contract, awarded on October 30, 2025, with an ultimate completion date of December 31, 2025, will be performed in Santa Clara, California. This award was made without a set-aside designation,...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $110,062.00 firm fixed-price delivery order is part of the VA Prosthetic Implants and Appliances 2016-2021 indefinite-delivery/indefinite-quantity (IDIQ) master contract. Abbott Vascular, a large medical device manufacturer, will provide cardiovascular and other medical products and services to support VA...
- This $105,425.00 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Abbott Laboratories Inc., through its Abbott Vascular Inc. division. The contract is for an EXPRESS REPORT: LVAD, with a completion date of August 15, 2018. Abbott Vascular, a large medical device manufacturer, has a history of providing cardiovascular products and services to the VA and Defense Health Agency. This award does not appear to have a set-aside...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $24,730 firm fixed price delivery order contract to Abbott Laboratories Inc.'s Abbott Vascular division for the supply of a surgical implant. The contract has a completion date of July 16, 2024. Abbott Laboratories Inc. is a large pharmaceutical and medical device manufacturer that provides a variety of products and services to U.S. government agencies, including the VA, through its Abbott Vascular division....
- Abbott Laboratories Abbott Vascular Inc. Division was awarded a one-year, firm fixed price purchase order valued at approximately fifty thousand dollars by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 (VA - VHA VISN 20) to provide surgical implants. The contract has a period of performance starting on August 23, 2023 through August 22, 2024. Abbott Vascular Inc. Division, a subsidiary of Abbott Laboratories, will deliver the surgical...
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a firm fixed-price purchase order valued at $470,000 by Veterans Integrated Service Network 16 (VISN 16), a civilian agency within the Department of Veterans Affairs. The contract, designated as "Assurance Elite Plan," was awarded on October 30, 2025, with an ultimate completion date of October 29, 2028, and will be performed in New Orleans, Louisiana. No set-aside designation was used in this procurement, indicating full and open competition among qualified vendors. Abbott Vascular's award reflects the company's established role as a critical supplier of advanced cardiovascular medical technologies to the VA healthcare system. As a division of Abbott Laboratories Inc., a global healthcare company headquartered in North Chicago, Illinois, Abbott Vascular specializes in sophisticated cardiovascular devices and related services that support complex medical procedures. This procurement follows Abbott's pattern of securing multiple significant contracts with various VA Integrated Service Networks for cardiovascular technologies, including stents, pacemakers, heart valves, and implantable cardiac monitoring systems, positioning the company as a strategic partner in federal healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $230.0k | 10/29/25 |